33342-406-06 : NDC 2026 Code

33342-406-06 : Dapagliflozin And Metformin Hydrochloride ( Dapagliflozin And Metformin Hydrochloride )

Additionally :

You can get information about “33342-406-06” NDC code in 33342-406-06 in HTML format

HTML | 33342-406-06 in TXT (Plain Text) format

TXT | 33342-406-06 in PDF (Portable Document Format)

PDF | 33342-406-06 in XML format

XML formats.

NDC Code : 33342-406-06 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "33342-406-06",
    "PackageDescription": "3 BLISTER PACK in 1 CARTON (33342-406-06)  / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (33342-406-66) ",
    "NDC11Code": "33342-0406-06",
    "ProductNDC": "33342-406",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Dapagliflozin And Metformin Hydrochloride",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Dapagliflozin And Metformin Hydrochloride",
    "DosageFormName": "TABLET, EXTENDED RELEASE",
    "RouteName": "ORAL",
    "StartMarketingDate": "20260406",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA211559",
    "LabelerName": "Macleods Pharmaceuticals Limited",
    "SubstanceName": "DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE",
    "StrengthNumber": "5; 500",
    "StrengthUnit": "mg/1; mg/1",
    "Pharm_Classes": "Biguanide [EPC], Biguanides [CS], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2026-04-07",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20271231",
    "StartMarketingDatePackage": "20260406",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}